Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66

Wei Zhang, Suying Dang, Jianhui Wang, Michael A. Nardi, Hong Zan, Paolo Casali, Zongdong Li

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Anti-platelet autoantibodies are frequently found in systemic lupus erythematosus (SLE) patients and contribute to the development of SLE-associated immunologic thrombocytopenia (SLE-ITP). Although the correlation of anti-dsDNA autoantibody with platelet-associated antibody has been reported, the potential mechanism underlying such a correlation is incompletely understood. We have reported that anti-platelet integrin GPIIIa49-66 (CAPESIEFPVSEARVLED) autoantibodies play a major role in the development of HIV-1-related thrombocytopenia (HIV-1-ITP). The strong negative charge of GPIIIa49-66 prompts us to investigate whether GPIIIa49-66 can be an epitope mimicking dsDNA. We report here that anti-GPIIIa49-66 antibodies are found in three out of nine SLE-ITP patients. Double-stranded (ds) DNA competitively inhibited the binding of purified patient anti-dsDNA antibodies to GPIIIa49-66 peptide. Both polyclonal and monoclonal anti-GPIIIa49-66 antibodies are able to cross-react with dsDNA. Consistent with previous reports, the DNA binding activities of anti-GPIIIa49-66 antibodies are mainly dependent on the positively charged amino acid in the heavy-chain complementarity-determining region 3 (HCDR3). The HCDR3 of human SLE anti-dsDNA monoclonal antibody (mAb) 412.67 demonstrates a similar positively charged amino acid chain orientation compared with that of anti-GPIIIa49-66 mAb A11, and it cross-reacts with GPIIIa49-66 peptide. Purified anti-GPIIIa49-66 antibodies from SLE-ITP patients are able to induce platelet fragmentation in vitro and to induce thrombocytopenia in vivo. Thus, our data suggest that specific epitope cross-reaction between GPIIIa49-66 and dsDNA could be a mechanism involved in the development of SLE-associated thrombocytopenia.

Original languageEnglish (US)
Pages (from-to)682-689
Number of pages8
JournalAutoimmunity
Volume43
Issue number8
DOIs
StatePublished - Dec 1 2010
Externally publishedYes

Fingerprint

Cross Reactions
Integrins
Systemic Lupus Erythematosus
Anti-Idiotypic Antibodies
Blood Platelets
Inosine Triphosphate
Antibodies
Thrombocytopenia
Autoantibodies
Complementarity Determining Regions
HIV-1
Epitopes
Monoclonal Antibodies
Amino Acids
Peptides
DNA

Keywords

  • anti-dsDNA autoantibody
  • Autoantibody
  • platelet-associated antibody (PAIgG)
  • systemic lupus erythematosus (SLE)

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66. / Zhang, Wei; Dang, Suying; Wang, Jianhui; Nardi, Michael A.; Zan, Hong; Casali, Paolo; Li, Zongdong.

In: Autoimmunity, Vol. 43, No. 8, 01.12.2010, p. 682-689.

Research output: Contribution to journalArticle

Zhang, Wei ; Dang, Suying ; Wang, Jianhui ; Nardi, Michael A. ; Zan, Hong ; Casali, Paolo ; Li, Zongdong. / Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66. In: Autoimmunity. 2010 ; Vol. 43, No. 8. pp. 682-689.
@article{1a6e7f678a5141c8b11f0ce2434e1025,
title = "Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66",
abstract = "Anti-platelet autoantibodies are frequently found in systemic lupus erythematosus (SLE) patients and contribute to the development of SLE-associated immunologic thrombocytopenia (SLE-ITP). Although the correlation of anti-dsDNA autoantibody with platelet-associated antibody has been reported, the potential mechanism underlying such a correlation is incompletely understood. We have reported that anti-platelet integrin GPIIIa49-66 (CAPESIEFPVSEARVLED) autoantibodies play a major role in the development of HIV-1-related thrombocytopenia (HIV-1-ITP). The strong negative charge of GPIIIa49-66 prompts us to investigate whether GPIIIa49-66 can be an epitope mimicking dsDNA. We report here that anti-GPIIIa49-66 antibodies are found in three out of nine SLE-ITP patients. Double-stranded (ds) DNA competitively inhibited the binding of purified patient anti-dsDNA antibodies to GPIIIa49-66 peptide. Both polyclonal and monoclonal anti-GPIIIa49-66 antibodies are able to cross-react with dsDNA. Consistent with previous reports, the DNA binding activities of anti-GPIIIa49-66 antibodies are mainly dependent on the positively charged amino acid in the heavy-chain complementarity-determining region 3 (HCDR3). The HCDR3 of human SLE anti-dsDNA monoclonal antibody (mAb) 412.67 demonstrates a similar positively charged amino acid chain orientation compared with that of anti-GPIIIa49-66 mAb A11, and it cross-reacts with GPIIIa49-66 peptide. Purified anti-GPIIIa49-66 antibodies from SLE-ITP patients are able to induce platelet fragmentation in vitro and to induce thrombocytopenia in vivo. Thus, our data suggest that specific epitope cross-reaction between GPIIIa49-66 and dsDNA could be a mechanism involved in the development of SLE-associated thrombocytopenia.",
keywords = "anti-dsDNA autoantibody, Autoantibody, platelet-associated antibody (PAIgG), systemic lupus erythematosus (SLE)",
author = "Wei Zhang and Suying Dang and Jianhui Wang and Nardi, {Michael A.} and Hong Zan and Paolo Casali and Zongdong Li",
year = "2010",
month = "12",
day = "1",
doi = "10.3109/08916934.2010.506207",
language = "English (US)",
volume = "43",
pages = "682--689",
journal = "Autoimmunity",
issn = "0891-6934",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66

AU - Zhang, Wei

AU - Dang, Suying

AU - Wang, Jianhui

AU - Nardi, Michael A.

AU - Zan, Hong

AU - Casali, Paolo

AU - Li, Zongdong

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Anti-platelet autoantibodies are frequently found in systemic lupus erythematosus (SLE) patients and contribute to the development of SLE-associated immunologic thrombocytopenia (SLE-ITP). Although the correlation of anti-dsDNA autoantibody with platelet-associated antibody has been reported, the potential mechanism underlying such a correlation is incompletely understood. We have reported that anti-platelet integrin GPIIIa49-66 (CAPESIEFPVSEARVLED) autoantibodies play a major role in the development of HIV-1-related thrombocytopenia (HIV-1-ITP). The strong negative charge of GPIIIa49-66 prompts us to investigate whether GPIIIa49-66 can be an epitope mimicking dsDNA. We report here that anti-GPIIIa49-66 antibodies are found in three out of nine SLE-ITP patients. Double-stranded (ds) DNA competitively inhibited the binding of purified patient anti-dsDNA antibodies to GPIIIa49-66 peptide. Both polyclonal and monoclonal anti-GPIIIa49-66 antibodies are able to cross-react with dsDNA. Consistent with previous reports, the DNA binding activities of anti-GPIIIa49-66 antibodies are mainly dependent on the positively charged amino acid in the heavy-chain complementarity-determining region 3 (HCDR3). The HCDR3 of human SLE anti-dsDNA monoclonal antibody (mAb) 412.67 demonstrates a similar positively charged amino acid chain orientation compared with that of anti-GPIIIa49-66 mAb A11, and it cross-reacts with GPIIIa49-66 peptide. Purified anti-GPIIIa49-66 antibodies from SLE-ITP patients are able to induce platelet fragmentation in vitro and to induce thrombocytopenia in vivo. Thus, our data suggest that specific epitope cross-reaction between GPIIIa49-66 and dsDNA could be a mechanism involved in the development of SLE-associated thrombocytopenia.

AB - Anti-platelet autoantibodies are frequently found in systemic lupus erythematosus (SLE) patients and contribute to the development of SLE-associated immunologic thrombocytopenia (SLE-ITP). Although the correlation of anti-dsDNA autoantibody with platelet-associated antibody has been reported, the potential mechanism underlying such a correlation is incompletely understood. We have reported that anti-platelet integrin GPIIIa49-66 (CAPESIEFPVSEARVLED) autoantibodies play a major role in the development of HIV-1-related thrombocytopenia (HIV-1-ITP). The strong negative charge of GPIIIa49-66 prompts us to investigate whether GPIIIa49-66 can be an epitope mimicking dsDNA. We report here that anti-GPIIIa49-66 antibodies are found in three out of nine SLE-ITP patients. Double-stranded (ds) DNA competitively inhibited the binding of purified patient anti-dsDNA antibodies to GPIIIa49-66 peptide. Both polyclonal and monoclonal anti-GPIIIa49-66 antibodies are able to cross-react with dsDNA. Consistent with previous reports, the DNA binding activities of anti-GPIIIa49-66 antibodies are mainly dependent on the positively charged amino acid in the heavy-chain complementarity-determining region 3 (HCDR3). The HCDR3 of human SLE anti-dsDNA monoclonal antibody (mAb) 412.67 demonstrates a similar positively charged amino acid chain orientation compared with that of anti-GPIIIa49-66 mAb A11, and it cross-reacts with GPIIIa49-66 peptide. Purified anti-GPIIIa49-66 antibodies from SLE-ITP patients are able to induce platelet fragmentation in vitro and to induce thrombocytopenia in vivo. Thus, our data suggest that specific epitope cross-reaction between GPIIIa49-66 and dsDNA could be a mechanism involved in the development of SLE-associated thrombocytopenia.

KW - anti-dsDNA autoantibody

KW - Autoantibody

KW - platelet-associated antibody (PAIgG)

KW - systemic lupus erythematosus (SLE)

UR - http://www.scopus.com/inward/record.url?scp=78149455162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149455162&partnerID=8YFLogxK

U2 - 10.3109/08916934.2010.506207

DO - 10.3109/08916934.2010.506207

M3 - Article

C2 - 20828249

AN - SCOPUS:78149455162

VL - 43

SP - 682

EP - 689

JO - Autoimmunity

JF - Autoimmunity

SN - 0891-6934

IS - 8

ER -